MedPath

Race-Specific Propofol Titration to Effect for Procedural Sedation

Completed
Conditions
Unconsciousness
Sedative Overdose
Hypoxemia
Apnea, Postanesthetic
Interventions
Procedure: Titrate propofol monotherapy infusion to effect
Registration Number
NCT03290859
Lead Sponsor
University of Florida
Brief Summary

Prospectively evaluate newly established guidelines and make clinicians aware of inter-racial difference in propofol sensitivity.

Detailed Description

The primary motivation in conducting this study is to conduct the implementation science, i.e., formalize and train, and retrain if needed, anesthesia providers in the standard practice of titrating infusion rate to effect and clinically evaluate the effect of race and ethnicity on propofol monotherapy sedation during GI endoscopy. The ultimate goal is to make it less likely that patients from races known to be sensitive to propofol experience inadvertent overdosing.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2780
Inclusion Criteria
  • Patients undergoing propofol sedation at Gainesville (GNV) and Jacksonville (JAX) GI Endoscopy suites
  • Age range 18 - 80 years old
  • Patients whose race can be identified from the electronic patient information chart (EPIC)
Read More
Exclusion Criteria
  • Patients who identify as multiracial in Epic
  • Patients who identify as Other in Epic
  • Patients who refuse to indicate their race in Epic
  • Patients whose race is listed as unknown in Epic
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Training interventionTitrate propofol monotherapy infusion to effectTrain anesthesia providers who deliver propofol sedation for GI endoscopy procedures to follow a uniform propofol monotherapy administration guideline to titrate propofol monotherapy infusion to effect according to a standardized protocol.
Primary Outcome Measures
NameTimeMethod
Change in the recovery times among races and ethnicitiesChange from baseline up to 24 hours

Monitored using aggregate data for metrics of recovery times

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UF Health

🇺🇸

Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath